Stock Updates

Today’s Top Gainers in the Market Teva Pharmaceutical Industries Limited (NYSE:TEVA) from Healthcare

Today’s top gainers include the company Teva Pharmaceutical Industries Limited (NYSE:TEVA) which is in the industry Drug Manufacturers – Other, gaining 1.24% today. In the last week its performance is -0.98%, and 2.68% for the past quarter. Currently, Teva Pharmaceutical Industries Limited, TEVA has a target price of 70.14, so today’s gain of 1.24% is a significant step towards its target price. The GAP today is therefore 0.32%.

Teva Pharmaceutical Industries Limited (NYSE:TEVA), has a market cap of 54453.59, and is based in Israel. Insider ownership is at 2.70%, and institutional ownership is 65.80%.

At the current price of 53.65, it has a dividend yield of 2.57%, and its target price is 70.14. This is with a profit margin of 6.90%, and total debt/equity of 0.36. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a P/E of 35.37, as well as a forward P/E of 8.93.

With a current EPS of 1.5, and a forecasted EPS growth for next year at 12.75%,Teva Pharmaceutical Industries Limited (NYSE:TEVA) has had a EPS growth for the past five years at -13.10%. For the next five years EPS growth is projected to be 5.35%.

Performance for the year is -20.38%. Since its IPO date on 3/26/1990, the total performance to date is -17.72%.

Volume today for Teva Pharmaceutical Industries Limited (NYSE:TEVA), is 1685913, while its average volume is 5504.16. Whilst the total gain today was 1.24%, it did have a day high of -4.34%.

Volatility for this week has been at 2.04%, and 1.99% for the month. The 52-week low for Teva Pharmaceutical Industries Limited, TEVA has been 12.46%, while the 52-week-high has reached -20.54%.

Looking at its return of investments, which is 5.70%, and its return on assets is 2.50%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an operating margin of 17.70%. With a sales growth of 1.40% quarter over quarter. Bearing in mind that Teva Pharmaceutical Industries Limited, TEVA is in the sector Healthcare, its long-term debt/equity is 0.27, and has a current ratio of 1.3 and 1 for quick ratio.

So what is the value of Teva Pharmaceutical Industries Limited? Well its PEG is 6.61, and the P/S is 2.79, along with a P/B of 1.61. Meanwhile it has a p/cash of 7.8.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment